Combretum erythrophyllum
Combretum erythrophyllum · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Combretum erythrophyllum is a versatile plant species utilized in various pharmacological studies due to its diverse chemical composition. Researchers have identified key bioactive compounds within its leaves, roots, seeds, and stems, including phenols, alkanes, and the potent Combretastatin A-1. Through preparations such as freeze-dried ground leaves and combined acetone extracts, the plant has demonstrated significant antibacterial activities against both Gram-negative and Gram-positive bacteria. Furthermore, studies have highlighted its complex biological impacts, ranging from apoptotic and cytotoxic effects to potential mutagenic properties. These findings underscore the medicinal importance of (-)-Combretastatin and other derivatives found within this botanical species.
- Synonyms
- Terminalia Erythrophylla · Combretum Glomeruliflorum Var. Riparium · 6 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Common Names
Combretum erythrophyllum is a versatile species widely recognized by several different regional identifiers. In many botanical circles, it is most frequently referred to by the common names Bushveld Willow or Bushveld-Willow. Beyond these standard English terms, the plant holds significant cultural importance and is known by various local names. Depending on the specific area, it may be called Chitiswati, Mbvuva, or Modubanoka. These diverse naming conventions highlight the deep connection between the plant and the various communities that inhabit its natural range.
Sources: Catalogue of Life (COL)
Synonyms
Combretum erythrophyllum is a taxonomically complex species that is associated with several important botanical synonyms. Scientific literature frequently links this plant to Combretum glomeruliflorum, including its specific varieties such as var. obscurum and var. riparium. Additionally, the taxon is recognized under the synonym Combretum erythrophyllum var. obscurum to account for regional variations. Further classifications include Combretum lydenburgianum, which is often treated as part of this broader group. Understanding these overlapping names is essential for accurate identification and botanical consistency.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Combretum erythrophyllum is a distinctive member of the kingdom Plantae. Within this vast biological group, it is classified under the class Equisetopsida. It belongs to the specific order Myrtales, which helps define its evolutionary lineage. Furthermore, this plant is a part of the Combretaceae family. Ultimately, its precise botanical identity is established within the genus Combretum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Combretum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Combretum erythrophyllum is a notable species widely distributed across various regions of the African continent. Its presence is particularly strong throughout South Tropical Africa, spanning countries such as Mozambique and Zimbabwe. The plant also maintains a significant footprint within Southern Africa, specifically thriving in the landscapes of Botswana and Eswatini. Additionally, its range extends into the Cape Provinces, showcasing its adaptability to diverse environmental conditions. This broad geographic spread highlights the plant's ecological importance across these interconnected southern territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Combretum erythrophyllum is a self-supporting tree that serves as a robust feature in its natural habitat. This species typically exhibits a versatile growth form, allowing it to establish a strong presence in various ecosystems. While it may reach a modest height of 12 meters, it has the potential to grow much larger. In optimal conditions, this impressive tree can attain a maximum height of up to 30 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Combretum erythrophyllum demonstrates a diverse range of biological activities that highlight its significant pharmacological potential. Research indicates that silver nanoparticles synthesized from its leaf and stembark extracts exhibit potent antibacterial, cytotoxic, and apoptotic properties against various bacterial strains and cancer cells. However, the plant's medicinal profile is complex, as studies have also identified mutagenic effects in certain bacterial strains. Specifically, extracts have shown mutagenicity in Salmonella typhimurium strains TA102 and TA100, with effects that can even be enhanced by the presence of an S9 mix. Understanding these multifaceted relationships is crucial for safely advancing the development of this plant for therapeutic applications.
Compounds
Combretum erythrophyllum serves as a significant botanical source for various potent bioactive compounds. Through the process of bioassay-guided fractionation of methanol extracts, researchers have identified key chemical constituents within the plant. Notably, the species contains combretastatin, a substance known for its biological activity. Specifically, the plant is confirmed to contain combretastatin A-1, which was isolated alongside other unique glucosides. These findings highlight the medicinal potential inherent in the chemical profile of Combretum erythrophyllum.
Conditions
Combretum erythrophyllum demonstrates significant medicinal potential through its ability to treat various fungal pathogens, including F. proliferatum and F. verticilloides. The plant's extracts also provide effective treatment against F. chlamydosporum and F. graminearum. Beyond its antifungal properties, a methanol extract of this species exhibits inhibitory bioactivities against DNA-damaging agents. These diverse biological activities highlight the plant's versatility as a source of natural bioactive compounds. Through these specific interactions, Combretum erythrophyllum serves as a potent agent against both pathogens and harmful biological processes.
Preparations
Combretum erythrophyllum is prepared as freeze dried and finely ground leaves for various antimicrobial screenings. The plant is also prepared as combined acetone extracts, which have demonstrated significant inhibition against certain Fusarium pathogens. Researchers utilize Combretum erythrophyllum as prepared in the form of general extracts to study biological activities and mutagenicity. Specifically, the plant is prepared as a leaf extract to facilitate the green synthesis of silver nanoparticles. Finally, a methanol extract of Combretum erythrophyllum has been used to isolate bioactive compounds like combretastatin in yeast-based assays.
Parts used
Combretum erythrophyllum is a medicinal plant characterized by several distinct anatomical parts that hold significant pharmacological potential. Research has demonstrated that the leaf and stem bark are particularly useful for the green synthesis of silver nanoparticles with antibacterial properties. Furthermore, the plant's root systems serve as a vital habitat for bacterial endophytes like Methylobacterium radiotolerans. The seeds of the species also play a crucial role, as they harbor specialized endophytes that contribute to the plant's overall antimicrobial and antioxidant profile. Together, these diverse components highlight the multifaceted biological value of this species in pharmaceutical research.